109 related articles for article (PubMed ID: 3532865)
1. On-line differential pulse polarographic detection of carboplatin in biological samples after chromatographic separation.
Elferink F; van der Vijgh WJ; Pinedo HM
Anal Chem; 1986 Sep; 58(11):2293-6. PubMed ID: 3532865
[No Abstract] [Full Text] [Related]
2. Analysis of antitumour [1,1-bis(aminomethyl)cyclohexane]platinum(II) complexes derived from spiroplatin by high-performance liquid chromatography with differential pulse amperometric detection.
Elferink F; van der Vijgh WJ; Pinedo HM
J Chromatogr; 1985 Mar; 320(2):379-92. PubMed ID: 4030937
[TBL] [Abstract][Full Text] [Related]
3. High-performance liquid chromatographic procedures for the analysis of carboplatin in human plasma and urine.
Gaver RC; Deeb G
Cancer Chemother Pharmacol; 1986; 16(3):201-6. PubMed ID: 3516429
[TBL] [Abstract][Full Text] [Related]
4. Determination of carboplatin in canine plasma by liquid chromatography with ultraviolet-visible detection and confirmation by atomic absorption spectroscopy.
Tyczkowska K; Page RL; Riviere JE
J Chromatogr; 1990 May; 527(2):447-53. PubMed ID: 2201694
[No Abstract] [Full Text] [Related]
5. The stability of carboplatin in ambulatory continuous infusion regimes.
Sewell GJ; Riley CM; Rowland CG
J Clin Pharm Ther; 1987 Dec; 12(6):427-32. PubMed ID: 3326888
[TBL] [Abstract][Full Text] [Related]
6. A sensitive postcolumn derivatization/UV detection system for HPLC determination of antitumor divalent and quadrivalent platinum complexes.
Kizu R; Yamamoto T; Yokoyama T; Tanaka M; Miyazaki M
Chem Pharm Bull (Tokyo); 1995 Jan; 43(1):108-14. PubMed ID: 7895301
[TBL] [Abstract][Full Text] [Related]
7. Extent of cisplatin formation in carboplatin admixtures.
Perrone RK; Kaplan MA; Bogardus JB
Am J Hosp Pharm; 1989 Feb; 46(2):258-9. PubMed ID: 2653024
[No Abstract] [Full Text] [Related]
8. Liquid chromatographic procedure for the quantitative analysis of carboplatin in beagle dog plasma ultrafiltrate.
Duncan GF; Faulkner HC; Farmen RH; Pittman KA
J Pharm Sci; 1988 Mar; 77(3):273-6. PubMed ID: 3286860
[TBL] [Abstract][Full Text] [Related]
9. Quality control of pharmaceutical formulations containing cisplatin, carboplatin, and oxaliplatin by micellar and microemulsion electrokinetic chromatography (MEKC, MEEKC).
Nussbaumer S; Fleury-Souverain S; Schappler J; Rudaz S; Veuthey JL; Bonnabry P
J Pharm Biomed Anal; 2011 May; 55(2):253-8. PubMed ID: 21330090
[TBL] [Abstract][Full Text] [Related]
10. Determination methods for the anticancer drug dicycloplatin, a supramolecule assembled through hydrogen bonding.
Yang X; Zheng J; Song Q; Xie F; Tang J; Chen J; Wu J; Li C; Cui W; Tang Y; Xie J; Zheng J
Analyst; 2015 Apr; 140(8):2704-12. PubMed ID: 25686082
[TBL] [Abstract][Full Text] [Related]
11. A novel method for speciation of Pt in human serum incubated with cisplatin, oxaliplatin and carboplatin by conjoint liquid chromatography on monolithic disks with UV and ICP-MS detection.
Martinčič A; Cemazar M; Sersa G; Kovač V; Milačič R; Ščančar J
Talanta; 2013 Nov; 116():141-8. PubMed ID: 24148385
[TBL] [Abstract][Full Text] [Related]
12. [Platinum derivatives].
Sasaki Y
Nihon Rinsho; 2004 Dec; 62 Suppl 12():452-5. PubMed ID: 15658361
[No Abstract] [Full Text] [Related]
13. New techniques in the pharmacokinetic analysis of cancer drugs. II. The ultratrace determination of platinum in biological samples by inductively coupled plasma-mass spectrometry.
McKay K
Cancer Surv; 1993; 17():407-14. PubMed ID: 8137350
[TBL] [Abstract][Full Text] [Related]
14. Determination of platinum-containing drugs in human plasma by liquid chromatography with reductive electrochemical detection.
Parsons PJ; Morrison PF; LeRoy AF
J Chromatogr; 1987 Jan; 385():323-35. PubMed ID: 3558589
[TBL] [Abstract][Full Text] [Related]
15. The pharmacology of carboplatin.
Van Echo DA; Egorin MJ; Aisner J
Semin Oncol; 1989 Apr; 16(2 Suppl 5):1-6. PubMed ID: 2655093
[No Abstract] [Full Text] [Related]
16. Capillary liquid chromatography with UV detection using N,N-diethyl dithiocarbamate for determining platinum-based antitumor drugs in plasma.
Otsuki Y; Kotani A; Kusu F
Chem Pharm Bull (Tokyo); 2012; 60(5):665-9. PubMed ID: 22689405
[TBL] [Abstract][Full Text] [Related]
17. Determination of intact oxaliplatin in human plasma using high performance liquid chromatography-tandem mass spectrometry.
Zhang W; Seymour L; Chen EX
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Dec; 876(2):277-82. PubMed ID: 19026601
[TBL] [Abstract][Full Text] [Related]
18. Determination of ethylenediamineplatinum(II) malonate in infusion fluids, human plasma and urine by high-performance liquid chromatography.
van der Vijgh WJ; Elferink F; Postma GJ; Vermorken JB; Pinedo HM
J Chromatogr; 1984 Oct; 310(2):335-42. PubMed ID: 6511851
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of a novel platinum anticancer compound HJ5 by high performance liquid chromatography].
Liu Y; He J; Liu ZD; Chen XZ; Liu WP
Se Pu; 2002 Jul; 20(4):345-7. PubMed ID: 12541919
[TBL] [Abstract][Full Text] [Related]
20. [Platinum derivatives].
Sasaki Y
Nihon Rinsho; 1999 Sep; 57 Suppl():425-7. PubMed ID: 10543144
[No Abstract] [Full Text] [Related]
[Next] [New Search]
